Cargando…
Effect of YAP1 silencing on esophageal cancer
BACKGROUND: YAP1, the nuclear effector of the Hippo pathway, has become an attractive target for treatment of malignancies and is a candidate oncogene in esophageal cancer (EC). We hypothesized that knockdown of YAP1 could suppress EC and could be used for targeted therapy. However, there are few re...
Autores principales: | Zhao, Jia, Li, Xiangnan, Yang, Yang, Zhu, Dengyan, Zhang, Chunyang, Liu, Donglei, Wu, Kai, Zhao, Song |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888714/ https://www.ncbi.nlm.nih.gov/pubmed/27307755 http://dx.doi.org/10.2147/OTT.S102338 |
Ejemplares similares
-
PAR1 and PAR4 exert opposite effects on tumor growth and metastasis of esophageal squamous cell carcinoma via STAT3 and NF-κB signaling pathways
por: Zhao, Jia, et al.
Publicado: (2021) -
Proteasome inhibitor MG132 inhibits the proliferation and promotes the cisplatin-induced apoptosis of human esophageal squamous cell carcinoma cells
por: DANG, LIFENG, et al.
Publicado: (2014) -
Long Non-coding RNA CASC2 Enhances the Antitumor Activity of Cisplatin Through Suppressing the Akt Pathway by Inhibition of miR-181a in Esophageal Squamous Cell Carcinoma Cells
por: Zhu, Dengyan, et al.
Publicado: (2019) -
Silencing of histone deacetylase 3 suppresses the development of esophageal squamous cell carcinoma through regulation of miR-494-mediated TGIF1
por: Yang, Yang, et al.
Publicado: (2022) -
MicroRNA let-7i Inhibits Histone Lysine Demethylase KDM5B to Halt Esophageal Cancer Progression
por: Yang, Yang, et al.
Publicado: (2020)